Drug-labels.com

Q-Pravastatin: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
10 mg, 20 mg, 40 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Q-Pravastatin

ABOUT THIS MEDICATION

What the medication is used for:

Q-PRAVASTATIN is available only with your physician's prescription. It is to be used as an adjunct to a medically recommended and carefully supervised diet for the long-term treatment of hypercholesterolemia and is not a substitute for such a diet. This has been shown to decrease the chances of experiencing a first or second heart attack, or stroke, and may help prevent heart disease if caused by cholesterol clogging the blood vessels, or slow the progression of atherosclerosis (hardening) of the arteries that nourish your heart, so-called coronary heart disease (CHD). In addition, depending on your condition, your physician may recommend an appropriate regimen of exercise, weight control and other measures.

What it Does:

Q-PRAVASTATIN lowers the level of cholesterol, particularly Low Density Lipoprotein (LDL) cholesterol, in the blood. Q-PRAVASTATIN reduces cholesterol production by the liver and induces some changes of cholesterol transport and disposition in the blood and tissues.

When it should not be used:

  • If you are pregnant, since its use in the event of

    pregnancy may harm the unborn. Only female patients who are highly unlikely to conceive can be candidates for Q-PRAVASTATIN treatment. In the event of pregnancy during treatment, Q-PRAVASTATIN should be discontinued and the physician should be informed.

  • If you know that you are allergic to pravastatin or

    any of the non-medicinal ingredients of Q-PRAVASTATIN.

  • If you have liver disease.
  • In adolescents and children since the safety of

    pravastatin in this age group has not been established.

What the medicinal ingredient is:

pravastatin sodium

What the important non-medicinal ingredients are:

crospovidone, FD&C blue # 2 aluminium lake (40 mg only), iron oxide red 30 (10 mg only), iron oxide yellow #10 (20 and 40 mg only), lactose anhydrous and magnesium stearate.

What dosage forms it comes in:

10 mg, 20 mg and 40 mg tablets

WARNINGS AND

WARNINGS AND PRECAUTIONS

Use only as specifically directed. Do not alter the dosage unless ordered to do so by your physician. Check with your physician before discontinuing medication since this may result in an increase of your blood lipids.

Before taking Q-PRAVASTATIN, tell your doctor or pharmacist if you:

  • are breast-feeding or intend to breast-feed,
  • have thyroid problems,
  • have a family history of muscular disorders,
  • had any past problems with the muscles (pain, tenderness), after using an HMG-CoA reductase inhibitor ("statin") such as atorvastatin (Lipitor®)3 fluvastatin (Lescol®)4, lovastatin (Mevacor®)5, pravastatin (Pravachol*), rosuvastatin (Crestor®)6 or simvastatin (Zocor®)5, or have developed an allergy or intolerance to them,
  • have kidney or liver problems,
  • diabetes,
  • have undergone surgery or other tissue injury,
  • do excessive physical exercise.

Pregnancy

Before using this medication, discuss the following with your doctor:

  • Cholesterol compounds are essential elements for the development of a fetus.

3 Lipitor® is a registered trademark of Pfizer Ireland Pharmaceuticals.

4 Lescol® is a registered trademark of Sandoz Canada Inc. 5 Mevacor® and Zocor® are registered trademarks of Merck & Co., Inc.

6 Crestor® is a registered trademark of IPR

Pharmaceuticals Inc.

  • Cholesterol-lowering drugs can harm the fetus. If you

    are of child-bearing age, discuss with your doctor the potential hazards to the fetus and the importance of birth control methods.

  • Q-PRAVASTATIN should not be used by pregnant

    women. If you become pregnant, discontinue use immediately and discuss with your doctor.

Slightly increased blood sugar can occur when you take HMG-CoA reductase inhibitor (“statin”). Discuss with the doctor your risk of developing diabetes.

H THIS MEDICATION

INTERACTIONS WITH THIS MEDICATION

Q-PRAVASTATIN may interact with other drugs, including those you take without a prescription. You must tell your doctor or pharmacist about all drugs, including prescription and non-prescription, herbal products and supplements, you are taking or planning to take before you take Q-PRAVASTATIN.

You should tell your doctor if you are taking other cholesterol lowering medication such as fibrates (gemfibrozil, fenofibrate), niacin, or ezetimibe. If you take these drugs and Q-PRAVASTATIN together, you may be at an increased risk of myopathy (muscle disease with aching or weakness).

If you are taking a bile acid-binding resin (such as cholestyramine, colestipol), your doctor will recommend that you take Q-PRAVASTATIN either one hour or more before or at least four hours following the resin. Taking them together causes lower amounts of Q-PRAVASTATIN in the blood, making it less effective.

If you are taking cyclosporine, your doctor may need to adjust the dose of Q-PRAVASTATIN.

Excessive alcohol intake should be avoided when taking Q-PRAVASTATIN. Tell your doctor if you regularly drink three or more alcoholic drinks daily.

E

PROPER USE OF THIS MEDICATION

  • Do not change the dose unless directed by a doctor.
  • Q-PRAVASTATIN should be taken as a single dose

    at bedtime, as prescribed by your physician.

  • Your physician will monitor your clinical condition

    and your blood tests at regular intervals. It is important to have these check-ups done on schedule. Please keep your appointments accurately.

  • Notify your physician about any illness which may

    develop during your treatment with Q-PRAVASTATIN and about any new prescription or non-prescription medication you may take. If you require medical help for other reasons, inform the attending physician that you are taking Q-PRAVASTATIN,

    • Notify your physician if you are going to have major surgery or have sustained a severe injury,
    • Notify your physician of any muscle pain, tenderness or weakness developing during treatment with Q-PRAVASTATIN (see SIDE EFFECTS AND WHAT TO DO ABOUT THEM).

Usual dose:

The recommended starting dose is 20 mg once daily at bed time. Patients who require a large dose reduction in LDL-C may be started at 40 mg once daily. The dose of 80 mg once daily should be reserved for patients who do not achieve their treatment goal with lower doses. Q-PRAVASTATIN may be taken without regard to meals.

Overdose:

There is no specific recommended therapy for overdose with Q-PRAVASTATIN.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT

THEM

Along with its intended action, any medication may cause unwanted effects.

Check with your physician as soon as possible if any of the following side effects occurs: aching muscles, muscle cramping, tiredness or weakness, fever and blurred vision.

Muscle effects

Side effects such as myalgia (muscle pain), myopathy (muscle disease with aching or weakness), rhabdomyolosis (a muscle wasting disease), associated tenderness, and rare cases of rhabdomylosis leading to kidney failure have been reported with other drugs of this class, known as HMG-CoA reductase inhibitors ("statins"), including Q-PRAVASTATIN.

As these muscle problems are on rare occasions serious, you should contact your physician promptly if you experience any of the side effects listed in the Table below.

Possible side effects reported with some statins: breathing problems including persistent cough and/or shortness of breath or fever, mood problems including depression, problems sleeping including insomnia and nightmares and sexual problems.

Poor memory, confusion and memory loss have also been reported with all statins.

Q-PRAVASTATIN can also cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with you doctor or pharmacist

Stop

taking drug and seek

immediate emergency medical attention

Only if

severe

In all cases
  • muscle pain that

    you cannot

    explain

  • muscle

    tenderness or muscle

    weakness

  • generalized

    weakness,

    especially if you do not feel well (ie. fever or

    fatigue)

  • brownish or

    discoloured

    urine

  • Symptoms of

    liver problems (upper belly pain, dark urine, itchy skin,

    nausea or

    vomiting, loss of appetite, pale stools,

    yellowing of skin or the

    whites of your eyes)

√

√

√

√

√
  • Increased Blood

    Sugar: Frequent urination, thirst and hunger

√

Other side effects may occasionally occur which usually do not require stopping treatment. They may come and go during treatment without any particular danger, but you should mention them to your physician, without undue delay, if they become persistent or bothersome. Such adverse experiences include abdominal pain, constipation, diarrhea, nausea, headache, dizziness and skin rashes.

This is not a complete list of side effects. For any unexpected effects while taking Q-PRAVASTATIN, contact your doctor or pharmacist.

HO

HOW TO STORE IT

W TORE IT

Q-PRAVASTATIN should be stored at room temperature (15-30°C). Protect from moisture and light. Keep in a safe place out of the reach of children.

MORE INFORMATION

This document can be found at:

www.qdpharmaceuticals.ca.

The full Product Monograph prepared for health professionals can be obtained by contacting the sponsor, QD Pharmaceuticals ULC at: 1-800-661-3429.

QD Pharmaceuticals ULC

85 Advance Road

Etobicoke, Ontario M8Z 2S6

Revised On: May 31, 2013

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete the Canada Vigilance Reporting

    Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E Ottawa, ON K1A 0K9

Postal paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect

NOTE: Should you require information related to the management of the side effect contact your health professional. The Canada Vigilance Program does not provide medical advice.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02370875

Revision date stated in the text: May 31, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Q-Pravastatin

Rx or OTC
Prescription (Rx)?
DIN 02370875, 02370891, 02370905
Schedule(s) PRESCRIPTION
Active ingredient(s) Pravastatin sodium
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA03 Pravastatin
Company QD PHARMACEUTICALS ULC
Current status Cancelled Pre Market
Current status date August 21, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02370875 10 MG Tablet Cancelled Pre Market August 21, 2015
02370891 20 MG Tablet Cancelled Pre Market August 21, 2015
02370905 40 MG Tablet Cancelled Pre Market August 21, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.